Frontlight ResearchEarly access
Trial site
Headlands Research- Sacramento
- 5running trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Obesity2 trials
- Alzheimer disease1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- High blood pressure1 trial
- Stroke1 trial
- Phase
- Phase 34 trials
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company2 trials
- Novartis Pharmaceuticals2 trials
- Pfizer1 trial
Running trials
Recruiting
Recruiting
Recruiting
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
Active, not recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity2 recruiting
- Alzheimer disease1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026